Male osteoporosis

Clinics in Geriatric Medicine

Volumn 26, Issue 2, 2010, Pages 301-309

  Ducharme, Nicole ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone mineral density; Male gender; Osteoporosis; Osteoporosis related fracture

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; PARATHYROID HORMONE[1-34]; PLACEBO; RISEDRONIC ACID; TESTOSTERONE; VITAMIN D;

ABDOMINAL PAIN; BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE STRENGTH; CLINICAL TRIAL; CONJUNCTIVITIS; DIZZINESS; DRUG ABSORPTION; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSPEPSIA; EXERCISE; EYE INFLAMMATION; FOOD; FOOD DRUG INTERACTION; FRAGILITY FRACTURE; GASTRITIS; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HIP FRACTURE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERURICEMIA; HYPOCALCEMIA; JAW OSTEONECROSIS; LEG CRAMP; LIQUID; MALE; MALE OSTEOPOROSIS; MUSCULOSKELETAL PAIN; NAUSEA; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; RESISTANCE TRAINING; REVIEW; SCLERITIS; SURVIVAL RATE; UVEITIS; VITAMIN SUPPLEMENTATION;

AGE FACTORS; AGING; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PREVALENCE; RISK FACTORS;

EID: 77953165150     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2010.02.005     Document Type: Review

References (54)

1. Eastell R., Boyle I.T., Compston J., et al. Management of male osteoporosis: report of the UK Consensus Group. QJM 1998, 91:71-92.
2. Gruntmanis U. Male osteoporosis: deadly, but ignored. Am J Med Sci 2007, 333:85-92.
3. Anderson F.H. Osteoporosis in men. Int J Clin Pract 1998, 52:176-180.
4. Cooper C., O'Neill T., Silman A. The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. Bone 1993, 14(Suppl 1):S89-S97.
5. Gloth F.M., Simonson W. Osteoporosis is underdiagnosed in skilled nursing facilities: a large-scale heel BMD screening study. J Am Med Dir Assoc 2008, 9:190-193.
6. Kiebzak G.M., Beinart G.A., Perser K., et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002, 162:2217-2222.
7. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and therapy Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
8. Campion J., Maricic M. Osteoporosis in men. Am Fam Physician 2003, 67:1521-1526.
9. Gennari L., Brandi M.L. Genetics of male osteoporosis. Calcif Tissue Int 2001, 69:200-204.
10. Khosla S. Role of hormonal changes in the pathogenesis of osteoporosis in men. Calcif Tissue Int 2004, 75:110-113.
11. Kaufman J.M., Johnell O., Abadie E., et al. Background for studies on the treatment of male osteoporosis: state of the art. Ann Rheum Dis 2000, 59:765-772.
12. Jemel A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 2003, 53:5-26.
13. Gilbert S., McKiernan M. Epidemiology of male osteoporosis and prostate cancer. Curr Opin Urol 2005, 15:23-27.
14. Mazees R., Ch Chestnut, McClung M., et al. Enhanced precision with dual-energy X-ray absorptiometry. Calcif Tissue Int 1992, 51:14-17.
15. Orwoll E. Assessing bone density in men. J Bone Miner Res 2000, 15:1867-1870.
16. Nelson H.D., Herfand M., Woolf S.H., et al. Screening for postmenopausal osteoporosis: a review of evidence for U.S. Preventive Task Force. Ann Intern Med 2002, 137:S29-S41.
17. Faulkner K.G., Orwoll E. Implications in the use of T-scores for the diagnosis of osteoporosis in men. J Clin Densitom 2002, 5:87-93.
18. Cummings S.R., Bates D., Black D.M. Clinical use of bone densitometry scientific panel. JAMA 2002, 188:1889-1897.
19. Mulleman D., Legroux-Gerot I., Duquesnoy B., et al. Quantitative ultrasound of bone in male osteoporosis. Osteoporos Int 2002, 13:388-393.
20. Wuster C., Hadji P. Use of quantitative ultrasound densitometry in male osteoporosis. Calcif Tissue Int 2001, 69:225-228.
21. Adler R. Epidemiology and pathophysiology of osteoporosis in men. Curr Osteoporos Rep 2006, 4:110-115.
22. Haney E., Bliziotes M. Male osteoporosis: new insights in an understudied disease. Curr Opin Rheumatol 2008, 20:423-428.
23. Bonnick S. Osteoporosis in men and women. Clin Cornerstone 2006, 8:28-39.
24. Dawson-Hughes B., Harris S.S., Krall E.A., et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670-676.
25. Miller E. Vitamin D insufficiency in male osteoporosis. Clin Cornerstone 2006, 8:S14-S19.
26. Braddy K.K., Imam S.N., Palla K.R., et al. Vitamin D deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis. J Am Med Dir Assoc 2009, 10:653-657.
27. Morley J.E. Vitamin D redux. J Am Med Dir Assoc 2009, 10:591-592.
28. Bonjour J., Gueguen L., Palacios C., et al. Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr 2009, 101:1581-1596.
29. Guadalupe-Grau A., Fuenes T., Guera B., et al. Exercise and bone mass in adults. Sports Med 2009, 39:439-468.
30. Moyad M. Osteoporosis part IV-rapid review of drug therapies (A to Z) for preventing male osteoporosis/fractures. Urol Nurs 2003, 23:168-174.
31. Kennel K., Drake M. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 2009, 84:632-638.
32. Orwoll E., Ettinger M., Weiss S., et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000, 343:604-610.
33. Gonnelli S., Cepollaro C., Montagnani A., et al. Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 2003, 73:133-139.
34. Miller P., Schnitzer T., Emkey R., et al. Weekly oral alendronic acid in male osteoporosis. Clin Drug Investig 2004, 24:333-341.
35. Ringe J.D., Orwoll E., Daifotis A., et al. Treatment of male osteoporosis: recent advances with alendronate. Osteoporos Int 2002, 13:195-199.
36. Boonen S., Orwoll E.S., Wenderoth D., et al. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 2009, 24:19-25.
37. Sato Y., Iwamoto J., Kanoko T., et al. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 2005, 165:1743-1748.
38. Sato Y., Iwamoto J., Kanoko T., et al. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005, 64:811-816.
39. Bodenner D., Redman C., Riggs A. Teriparatide in the management of osteoporosis. Clin Interv Aging 2007, 2:499-507.
40. Bilezikian J.P., Kurland E.S. Therapy of male osteoporosis with parathyroid hormone. Calcif Tissue Int 2001, 69:248-251.
41. Orwoll E.S., Scheele W.H., Paul S., et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003, 18:9-17.
42. Finkelstein J., Hayes A., Hunzelman J., et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003, 349:1216-1226.
43. Kurland E., Heller S., Diamond B., et al. The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide. Osteoporos Int 2004, 15:992-997.
44. Morley J.E. Androgens and aging. Maturitas 2001, 38:61-71.
45. Harman S.M., Metter E.J., Tobin J.D., et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001, 86:724-731.
46. Snyder P., Peachey H., Berlin J., et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000, 85:2670-2677.
47. Snyder P., Peachey H., Hannoush P., et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999, 84:1966-1972.
48. Amin S. Male osteoporosis: epidemiology and pathophysiology. Curr Osteoporos Rep 2003, 1:71-77.
49. Seeman E. Unresolved issues in osteoporosis in men. Rev Endocr Metab Disord 2001, 2:45-64.
50. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
51. Abellan van Kan G., Rolland Y.M., Morley J.E., et al. Frailty: toward a clinical definition. J Am Med Dir Assoc 2008, 9:71-72.
52. Morley J.E. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
53. Abellan van Kan G., Rolland Y., Bergman H., et al. The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008, 12:29-37.
54. Flaherty J.H., Morley J.E., Murphy D.J., et al. The development of outpatient clinical glidepaths. J Am Geriatr Soc 2002, 50:1886-1901.